A: 1- The new viral recombinant vaccine expressing antigen 85A is efficient in human clinical trials
B: 2- Several vaccine candidates based on MVA (Modified Virus Ankara) are protective in human clinical trials
C: 3- The recombinant MVA vaccine expressing antigen 85A is protective in pre-clinical tests
举一反三
- 重组抗原疫苗（recombinant antigen vaccine）
- The vaccine for measles is best characterized by() A: Bacteriocin B: Killed virus vaccine C: Inactivated virus vaccine D: Live virus vaccine E: Recombinant virus vaccine
- Which of the following means a measured portion of medicine taken at any one time? A: vaccine B: antigen C: immunogenicity D: dosage
- He said that trials would be ________ in African countries to test a tuberculosis vaccine against the new coronavirus.
- 1. Which is the first vaccine? A: Smallpox vaccine B: Measles vaccine C: mumps vaccine D: Rubella vaccine
内容
- 0
PubMed提供的Clinical Queries服务的Clinical Study Categories部分可用于查找疾病哪一方面的文献？（） A: Systematic Reviews B: Medical Genetics C: Prognosis D: Clinical trials
- 1
Reliable information should be available to （） A: for some patients B: before participation C: in humans D: medical knowledge E: during the trial F: candidates for clinical trials
- 2
Why should Geron discuss its plans with FDA before starting the first clinical trials?
- 3
Q25 – Which proposal is correct? A: 1- ESX-1-deficient and -proficient mycobacteria impact in a similar manner the host immune system B: 2- Genetic engineering of ESX-1 secretion system in new live-attenuated vaccine candidates is feasible C: 3- The host adaptive immunity is tolerized against ESX-1-associated antigens
- 4
Which of the following is an example of a sickness that can be prevented by a vaccine?